Monopar Therapeutics Inc. · NASDAQ:MNPR

Hendricks Diane reported a 13.40% stake in Monopar Therapeutics Inc. (Schedule 13D/A)

Event Dec 9, 2024 · Filed Feb 7, 2025

Hendricks Diane reported a 13.40% stake in Monopar Therapeutics Inc., 704,829 shares, with active intent on Dec 9, 2024. Filed Feb 7, 2025 (Schedule 13D/A).

Stake
13.40%
Shares
704,829
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Monopar Therapeutics11.60%611,079
Hendricks Diane13.40%704,829
Leo Karl13.40%642,391
Pharma Investments LLC11.60%611,079

Source

View original at SEC

Related